PLG and cerebral microbleeds: This molecular mechanism results in a “double-hit” pathology: systemic fibrinolytic activity depletes clotting factors, while localized plasmin production disrupts the blood–brain barrier (BBB), predisposing to cerebral microbleeds and parenchymal hemorrhage (19).